Intensive electroconvulsive therapy in drug resistant neuroleptic malignant syndrome - Case report

Psychiatria Danubina

Volumn 24, Issue 2, 2012, Pages 219-222

  Wysokiński, Adam ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; ATROPINE; BROMOCRIPTINE; C REACTIVE PROTEIN; CEFUROXIME; CLEMASTINE; CLOZAPINE; CREATINE KINASE; DANTROLENE; DIAZEPAM; ETOMIDATE; FLUCONAZOLE; FUROSEMIDE; GLUCOSE; HALOPERIDOL; HEPARIN; IRON; LORAZEPAM; MANNITOL; METOPROLOL; METRONIDAZOLE; NADROPARIN; POTASSIUM; PROPOFOL; NEUROLEPTIC AGENT;

ADULT; ANEMIA; ARTICLE; ARTIFICIAL VENTILATION; AUDITORY HALLUCINATION; BACTERIAL INFECTION; BRAIN INFECTION; CASE REPORT; CATATONIC SCHIZOPHRENIA; CEREBROSPINAL FLUID ANALYSIS; CONTRACTURE; COOLING; CREATINE KINASE BLOOD LEVEL; DEEP VEIN THROMBOSIS; DEFENSE MECHANISM; DIAPHORESIS; DIET SUPPLEMENTATION; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ELECTROCONVULSIVE THERAPY; FEVER; HEBEPHRENIA; HUMAN; HYPERSALIVATION; HYPOKALEMIA; INSOMNIA; INTENSIVE CARE UNIT; LEG ULCER; LEUKOCYTE COUNT; MALE; MUSCLE RIGIDITY; NASOGASTRIC TUBE; NEUROIMAGING; NEUROLEPTIC MALIGNANT SYNDROME; NUCLEAR MAGNETIC RESONANCE IMAGING; PARANOID SCHIZOPHRENIA; PERSECUTORY DELUSION; PHYSICAL EXAMINATION; PROTEIN BLOOD LEVEL; PSYCHIATRIC DEPARTMENT; PSYCHOSIS; REHABILITATION; REHYDRATION; RESPIRATORY FAILURE; RESPIRATORY TRACT INFECTION; RESPIRATORY TRACT INTUBATION; RESTLESSNESS; TACHYCARDIA; THRUSH; TREMOR; URINARY CATHETER; URINARY TRACT INFECTION; VERBAL HOSTILITY; METHODOLOGY;

ADULT; ANTIPSYCHOTIC AGENTS; CLOZAPINE; ELECTROCONVULSIVE THERAPY; HALOPERIDOL; HUMANS; MALE; NEUROLEPTIC MALIGNANT SYNDROME;

EID: 84864875146     PISSN: 03535053     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Caroff SN, Rosenberg H, Fletcher JE, Heiman-Patterson TD, Mann SC: Malignant hyperthermia susceptibility in neuroleptic malignant syndrome. Anesthesiology 1987; 67: 20-25.
2. Caroff SN, Mann SC: Neuroleptic malignant syndrome. Psychopharmacol Bull 1988; 24: 25-29.
3. Caroff SN, Mann SC: Neuroleptic malignant syndrome. Med Clin North Am 1993; 77: 185-202.
4. Caroff SN, Mann SC, Campbell EC: Atypical antipsychotics and neuroleptic malignant syndrome. Psychiatric Annals 2000; 30: 314-321.
5. Harland CC, O'Leary MM, Winters R, Owens J, Hayes B, Melikian V: Neuroleptic malignant syndrome: a case for electroconvulsive therapy. Postgrad Med J 1990; 66: 49-51.
6. Mann SC, Caroff SN, Fricchione GE, Campbell EC: Central dopamine hypoactivity and the pathogenesis of neuroleptic malignant syndrome. Psychiatr Ann 2000; 30: 363-374.
7. Manu P, Sarpal D, Muir O, Kane JM, Correll CU: When can patients with potentially life-threatening adverse effects be rechallenged with clozapine? A systematic review of the published literature. Schizophr Res 2011. [Epub ahead of print]
8. Pope HGJ, Aizley HG, Keck PEJ, McElroy SL: Neuroleptic malignant syndrome: long-term follow-up of 20 cases. J Clin Psychiatry 1991; 52: 208-212.
9. Sachdev P, Kruk J, Kneebone M, Kissane D: Clozapineinduced neuroleptic malignant syndrome: review and report of new cases. J Clin Psychopharmacol 1995; 15: 365-371.
10. Strawn JR, Keck PEJ, Caroff SN: Neuroleptic malignant syndrome. Am J Psychiatry 2007; 164: 870-876.
11. Trollor JN, Sachdev PS: Electroconvulsive treatment of neuroleptic malignant syndrome: a review and report of cases. Aust N Z J Psychiatry 1999; 33: 650-659.
12. Yacoub A, Kohen I, Caraballo A, Francis A: Rating Scale for Neuroleptic Malignant Syndrome. Biol Psychiatry 2004; 55: 89S.
13. Živković M, Mihaljević-Peleš A, Šagud M, Silić A, Mihanović M: The role of CYP2D6 and TAQI A polymorphisms in malignant neuroleptic syndrome: two case reports with three episodes. Psychiatr Danub 2010; 22: 112-116.